Small-Molecule PIK-93 Modulates the Tumor Microenvironment to Improve Immune Checkpoint Blockade Response

Researchers discovered small-molecule drugs that can modulate the tumor microenvironment to enhance immune checkpoint inhibitors treatment efficacy in non–small cell lung cancer in vitro and in vivo.